Year-end report 2016

The Board and Chief Executive Officer of Cereno Scientific AB herewith present the year-end report for the financial year 2016.

Read more here…

Calendar

Interim report Q1 24 May 2017

Interim report Q2 & H1 23 August 2017

Interim report Q3 14 November 2017

Cereno Scientific

(Video in Swedish) Cereno Scientific is developing a new preventive drug that normalizes the body’s own defence system against blood clots - to be used on the global market for the treatment of complications resulting from thrombosis-related cardiovascular diseases.

About Cereno Scientific